INCB-059064

N/A

Report date: 2025/01/26 16:37:44
NME

Base Information

Drug NameINCB-059064
Drug Alias NameLSD1 inhibitor (Incyte)INCB-059064
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHemoglobin subunit gamma stimulantsLysine-specific histone demethylase 1 inhibitors
TargetsLysine-specific histone demethylase 1Hemoglobin subunit gamma
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesIncyte Corp
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A